HIGHLIGHTS
- who: MDPI from the Department of Urology Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science , Department of Radiation Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China have published the Article: Type of the Paper (Article, in the Journal: Cancers 2022, 14, 3782. of /2022/
- what: Our research found a new molecule, NXPH4, which influences the prognosis of patients with bladder cancer, and revealed that NXPH4 promotes progression, metastasis, and gemcitabine resistance in bladder cancer by enhancing glycolysis through modulating the expression of NDUFA4L2.
- how: The results showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.